Abstract: Non-porous monodispersed strontium containing bioactive glass (Si 2 O-CaO-SrO) nanoparticles (SrBGNPs), were synthesised using a modified Stöber process. Silica nanoparticles (Si-NPs) with diameters 90 ± 10 nm were produced through hydrolysis and polycondensation reactions of the silicon alkoxide precursor, tetraethyl orthosilicate (TEOS), prior to the incorporation of cations; calcium (Ca) and strontium (Sr), into the silica networks through heat treatment (calcination). Sr was substituted for Ca on a mole basis from non-(0SrBGNPs) to fullsubstitution (100SrBGNPs) in order to increase the amount of network modifiers in the Si-NPs. The different ratios of Si: Ca; 1:1.3 and 1:8.0, presented various elemental compositions (i.e. 77-92 mol% of SiO 2 ). The effect of Si: Ca/Sr ratio on particle size, morphology and dispersity was evaluated, as well as the in vitro cell viability effect of SrBGNPs and their dissolution products on pre-osteoblast cell line, MC3T3-E1. Sr incorporation did not affect particle size or dispersity. For 1:1.3 ratio, SrBGNPs caused no toxic effects on the cells and dissolution products of 75-and 100-SrBGNPs showed great potential to promote MC3T3-E1 activity.
Introduction
Bioactive glasses (BGs) have capacity to bond with bone [1] and stimulate bone regeneration [2] [3] [4] . Bioactive glass nanoparticles (BGNPs) can be used as the therapeutic carriers that enable sustained release of ions from their amorphous structure during dissolution [5] [6] [7] . Nanoparticles (NPs) have the potential benefit over microparticles of entering a cell, accumulating inside the lysosome and delivering their therapeutic ions from within the cell [8, 9] . One of the most effective methods to synthesise BGNPs is the sol-gel process in which a silicon alkoxide precursor, such as tetraethyl orthosilicate (TEOS), is simultaneously hydrolysed and poly-condensed to form the silica network under either acid or base conditions [4] . In 1968, Stöber developed the process to synthesise the monodispersed silica microparticles with spherical morphology and size range from 0.05 to 2 µm based on the sol-gel process under basic conditions [10] . Greasley et al. reported the modification of the Stöber process, and investigation of the many process variables, to understand and control size of the Si-NPs and to incorporate network modifiers while maintaining their monodispersity [11] . Ammonium hydroxide concentration, a basic catalyst, plays a critical role to control size of the particles [11] . When ammonium hydroxide concentration increased, the particle size increased. The increase in the pH to above the isoelectric point of soluble silica caused particles to repel each other, resulting in monodispersity [12] . Calcium (Ca) is a network modifier in the BG [11, 13, 14] . The traditional sol-gel precursor for incorporation Ca is calcium nitrate [15] . However, thermal processing above 450 ∘ C is needed for Ca to become a network modifier [13, 14] . Greasley et al. determined that the most effective use of calcium nitrate was to form monodisperse Si-NPs prior to calcium nitrate addition and thermal treatment [11] . The appropriate ratio of Si to Ca (Si: Ca) is the key parameter to maintain the monodispersity of the particles [9] and the modified Stöber process allowed a maxi-mum of 10% mol CaO incorporation into the binary bioactive glass system (90% mol Si and 10% mol Ca), a ratio of Si: Ca of 1: 1.3 [11] . Here, we hypothesised that increasing the number of network modifying components would increase total cation content and cations that could be released from BGNPs, which is likely to be beneficial for bone regeneration. Therefore, some Ca was replaced with strontium (Sr) and the ratio of modifiers (Ca+Sr) to Si was increase to reduce the connectivity of the silicate network. Strontium (Sr) was chosen due to its therapeutic potential. Strontium ranelate (SrR), marketed as Protelos , has been used as a drug for osteoporosis treatment [16] . SrR hinders bone resorption because it has the ability to induce osteoclast apoptosis [17] and to inhibit osteoclast differentiation [18] . It is well known that Sr ions have the great potential to maintain healthy bones [19] . Sr containing BGs have been shown to stimulate osteogenic differentiation of periodontal ligament cells [20] and mesenchymal stromal cells [21] because of its properties to enhance bone formation and to inhibit bone resorption [22] .
Melt-derived bioactive glass nanoparticles have been produced, however, melt-derived glasses have many components, e.g. Na is a network modifier to lower the melting point of the glass [23] . When considering a silicate nanoparticle as a reservoir of active ions and potentially a device for controlled delivery of therapeutic ions, more simple compositions are needed. Binary or tertiary compositions can be made using the sol-gel process. Sr was also introduced into melt-derived BGNPs, which promoted osteogenic differentiation of human bone marrow stromal cell [23, 24] . Here, the aim was to incorporate Ca and Sr into the 80-100 nm monodispersed Si-NPs using the modified Stöber process and to increase total amount of network modifiers in order to improve the biological properties of the SrBGNPs.
Methods

Nanoparticle synthesis
Dense monodispersed Si-NPs were synthesised using the modified Stöber process [11] . To fabricate Si-NPs with 80-100 nm in diameter, 32.9 ml of ethanol (ethyl alcohol, 200 proof, P99.5%), 4.1 ml of distilled water, and 0.5 ml of ammonium hydroxide (ACS reagent, 28.0-30.0%) were mixed in an ultrasonication bath for 10 minutes. 2.5 ml of TEOS (tetraethyl orthosilicate, reagent grade, 98%) was gently added to the mixed solution and left in the ultrasonication bath at least 6 h to complete hydrolysis and polycondensation reactions. A transplanted solid pellet of Si-NPs was collected by centrifugation at 7830 rpm for 40 minutes and then were washed in ethanol two times before being re-suspended in distilled water. The following step was adding Ca and Sr.
In a series of SiO 2 -CaO bioactive glass with nominal ratio of SiO 2 : CaO of 1:1.3 ratio, 0.36 M of calcium nitrate tetrahydrate (ACS reagent, 99%) was dissolved in distilled water and then was added to the silica particle suspension. Sr was substituted for calcium on a mole percentage basis from 0 to 100% substitution; 0, 25, 50, 75, and 100%. Strontium nitrate dihydrate (ACS reagent, 99%) was replaced for calcium nitrate tetrahydrate (ACS reagent, 99%). This solution was mixed in the ultrasonication bath for 30 minutes and was centrifuged to collect the white pellet particles. The pellet of particles was completely dried at 60 ∘ C overnight.
To incorporate Ca and Sr, the dried particles were heated to 680 ∘ C for 3 h at a heating rate 3 ∘ C min −1 and then were furnace cooled to room temperature. The particles were carefully washed with ethanol three times to remove excess Ca and Sr which were not incorporated into the particles. The cleaned particles were dried at 60 ∘ C overnight.
A series of different Si:Ca/Sr ratio (1:8.0) were synthesised using the same process.
Particle characterisation
To investigate size distribution of particles, each sample was diluted in ethanol followed by 30 minutes ultrasonication before measuring using dynamic light scattering (DLS, Malvern instrument 2000). To confirm size and morphology of particles, the samples were imaged using bright field transition electron microscopy (TEM). Particles were collected on 400 mesh copper Transmission Electron Microscopy (TEM) grids, coated with holey carbon film. TEM images were performed with a JEOL 2000FX microscope operating at 200 kV. To indicate the stability of particles in solutions, Zeta (ζ ) potential values were measured in distilled water at pH 7.4 using Zeta sizer (Malvern instrument 2000).
To determine the elemental composition of each particle type, samples were prepared through an acid digestion method, 50 mg of finely ground particle was mixed carefully with 250 mg of anhydrous lithium metaborate (80% w/w) and lithium tetraborate (20% w/w) in a clean and dry platinum crucible using a glass rod. The mixture was fused in a furnace for 20 minutes at 1050 ∘ C and then left to cool.
The substances were then immersed and completely dissolved in 2 M nitric acid [8] and then were measured using inductively coupled plasma optical emission spectroscopy (ICP-OES, Thermo Scientific ICap 6000series).
Dissolution studies
Artificial lysosomal fluid (ALF) solution pH 4.5, which mimics the pH and salt condition in the natural lysosome [25] , was used to study the release of the therapeutic ions from the NPs. This is because when nanoparticles enter cells by endocytosis, they will be encapsulated by a lysosome after they pass through the cell membrane [8, 9] . Depending on how the nanoparticle behaves in the lysosome, the particles may be released into the cytoplasm. It is therefore important to predict how the particles degrade in fluid that mimics the internal environment of a lysome, i.e. ALF [11] .
To compare released profiles of particles, 75 mg of each sample was suspended in 5 ml of ALF pH 4.5, according to recommendation proposed by Maçon et al. [26] . This mixture was placed in dialysis tubing and closed with a dialysis tubing closure clips before placing in the solution to a final volume of 50 ml in a 100 ml polyethylene bottle. All samples were incubated in an incubator shaker at 37 ∘ C, 120 rpm for 1, 2, 3, 4, 5, 6, 7, 24, 48, 72, 96, 168, 240 h. At the end of each incubation time, 1 ml of the bulk solution was collected and then replaced with 1 ml of the fresh solution.
The collected solution was diluted in 2 M nitric acid with a 10-fold dilution factor. The released ions were measured using ICP-OES.
Cytotoxicity study
MC3T3-E1 cells, a clonal pre-osteoblastic cell line derived from new-born mouse calvaria, were cultured in basal α-MEM (Gibco) supplemented with 10% fetal bovine serum (FBS) (v/v), 100 U·ml −1 penicillin and 100 µg·ml −1 streptomycin. MC3T3-E1 cells were seeded at a concentration 5 × 10 4 cells·ml −1 in a flat-bottomed 96-well plate and incubated at 37 ∘ C and 5% CO 2 for 24 h to allow cells to attach and expand.
To evaluate the toxicity of particles, cell viability was measured using a pulse-chase exposure, where cells were exposed to pulse of particles for 24 h followed by chase period of 1, 3 and 7 days. Cells were seeded in 96 well plates at a concentration 1 × 10 5 cells ml −1 . After 24 h incubation, the cell-culture media was replaced with basal α-MEM containing NPs at concentration range from 0-250 µg ml −1 . This range was chosen because higher concentrations of bioactive glass compositions (Sr-free) were previously found to cause some toxicity to stem cells due to the large volumes incorporated into the cells [8, 9] . Following pulse period (24 h incubation), cells were maintained in basal α-MEM containing no particles with media change every 3 days. The cell viability of MC3T3-E1 cells was determined using a calorimetric assay based on the conversion of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) into formazan (Invitrogen, Molecular Probes TM ).
To investigate the effect of dissolution products released from SrBGNPs, ion dissolution media were prepared in a serial concentration range from 0-250 µg ml −1 .
These particles were incubated in plain α-MEM in an incubator shaker at 37 ∘ C, 120 rpm for 4 h and then were filtrated through a sterilised filter. After particles were removed from the media, 10% foetal bovine serum (FBS) (v/v), 100 U ml −1 penicillin and 100 µg ml −1 streptomycin were supplemented. The ionic elements in the dissolution products were determined using ICP-OES. The cells were incubated with the same media for 24 h prior to culture in basal medium for further 7 days.
Statistical analysis
All data are expressed as mean ± standard deviation (SD) unless otherwise noted. P-values < 0.05 are considered as statistically significant. Statistical analysis was performed using one-way ANOVA to compare various groups.
Results
When the Si:Ca/Sr ratio was 1:1.3 , the amount of Sr substitution did not affect the size and morphology of the particles confirmed using DLS (Table 1 ) and TEM ( Figure 1 ). Based on previous research [7] , the concentration of ammonium hydroxide is the key factor to control size of particles. In this study, 0.30 M of ammonium hydroxide was chosen to synthesise 80-100 nm particles. The DLS results show that the particle size distributions were 90±10 nm (Table 1) , confirmed by TEM images (Figure 1 .) The surface charge of the particles was another parameter to investigate in terms the dispersion stability of the particles in solutions. The ζ -potential of each particles was measured in deionized water at pH 7.4. In both ratios, particles shows the negative charges on the particles' surface (Table 1) . When the ratio of Si: Ca/Sr increased from 1:1.3 to 1:8.0, the excess salts caused particles to aggregate after heating to 680 ∘ C (Figure 2 ). To remove the excess unincorporated Ca and Sr on the surface of particles, an extra washing step with 1 M nitric acid was added. Figure 2 also shows the monodispersed particle after the extra washing step. These results indicated that there is an upper limit of network modifier incorporation into the dense Si-NPs. Not all of the nominal Ca and Sr added incorporated into the silica network. The excess Ca and Sr components were carefully washed in the extra washing step before the elemental components were analysed. Table 2 shows the elemental components of SrBGNPs. As %Sr substitution increased, the overall amount of network modifiers increased. This might be because the ionic radius of strontium (0.112 nm) is larger size compared to calcium (0. solution pH for each sample did not significant change over the study period (Figure 4) , which is impo rtant a large pH change could cause toxicity or another change in cellular response. TEM images also show that Sr-BGNPs with Si:Ca/Sr ratio of 1:8.0 changed in morphology over 10 days of immersion in ALF solution ( Figure 5 ) to much great extent compared to Sr-BGNPs with Si:Ca/Sr ratio of 1:1.3. Dissolution of the nanoparticles was also evident in the TEM images after 10 days of immersion in ALF (Figure 5) as the particles reduced in density. The reduction in density was greater for nanoparticles containing increased strontium. Cellular cytotoxicity was evaluated using the MTT assay. The study was divided into two parts: direct method in which particles were in direct contact with the cells; and dissolution ion method in which only released ions from the particles were used to incubate cells. In the case of the direct method, after 24 h of the pulse treatment, the results of the chase phase for 0, 1, 3 and 7 days showed low cytotoxicity (< 30%) for all particle concentrations. For Sr-BGNPs with Si:Ca/Sr ratio of 1: 1.3, no obvious change in cell viability was identified, even up to the concentration of 250 µg·ml −1 (Figure 6a ). In contrast, for SrBGNPs with Si:Ca/Sr ratio of 1:8.0, more than 30 % reduction in cell viability was observed (Figure 6b) . Interestingly in the case of dissolution method, after 3 and 7 days of culture, the cell viability of MC3T3-E1 cells treated with dissolution ions from 75SrBGNPs and 100Sr-BGNPs with Si:Ca/Sr ratio 1:1. 
Discussion
BG submicron particles and NPs have been reported to stimulate bone proliferation and differentiation [8, 9, 23] .
In this study, we have developed dense monodispersed Sr-BGNPs for osteogenic applications to provide an injectable alternative method for bone regeneration applications using the modified Stöber process [11] . Nanoparticles that can deliver strontium ions in conjunction with solu- ble silica and calcium ions have the potential to treat osteoporosis by reducing osteoclast activity and promoting osteoblast activity. According to the Stöber process, ammonium hydroxide, which acts as the basic catalyst, was used to produce a sub-micron colloidal particle in the solution [12] . The pH of the reaction, was above the isoelectric point of the soluble silica (i.e. the isoelectric point of silica in water is around pH 2), directly affecting the repulsion between newly and formed Si-NPs in the aqueous solution [12] . This condition causes NPs to be stable in the spherical particle form in the solution. Here, the target size of particles was in the range of 80-100 nm, to and facilitate endocytosis and internalisation and to reduce the chance of toxicity [27] . 0.5 ml of ammonium hydroxide gave Si-NPs diameters, in the target range ( Figure 1 , Table 1 ). The sol-gel process involves the synthesis of colloidal solution (sol) which is composed of the hydrolysed alkoxide precursor, TEOS. As a result, poly-condensation of Si-OH occurs to form the silica network (-Si-O-Si-). To modify the silica network, calcium nitrate and strontium nitrate were used as the precursor sources of network modifiers. Previous work showed that calcium incorporation was much lower than the nominal value, but here, using strontium and calcium combinations, the total cation content of the NPs was increased. (Table 2 ). The reason behind this effect is that the ionic radii of strontium (0.112 nm) has a larger size compared to calcium (0.099 nm), leading to the less compact of the silica networks. Sr substitution did not affect size and shape of the particles.
However, the overall amount of network modifiers increased only 1.6-1.8 fold when the ratio of Si:Ca/Sr increased from 1:1.3 to 1:8.0 (6.15-fold). These results confirmed that for Si:Ca/Sr 1:8.0 ratio particles, the excess of Ca and Sr could not enter into the Si-NPs. This formulation also needed the extra step to wash with 1 M nitric acid to remove the un-incorporated salts from the particle surface ( Figure 2) .
Binary NPs containing single modifiers 0SrBGNPs (only Ca) and 100SrBGNPs (only Sr) released less cations compared with the ternary glasses. The reason behind this effect might be caused by the mixed alkali effect in the BG composition, wherein alkali ion movement changes when two modifiers are present, changing physical properties of glass [28] [29] [30] .
The response of MC3T3-E1 pre-osteoblasts was tested because MC3T3-E1 are widely available osteoprogenitor cells. If the particles are to be used in therapy, e.g. for osteoporosis, it is important that the particles do not cause toxicity for cells such as these that are responsible for bone regeneration. Murine cells were chosen because they are well characterised. Although the particles with a Si:Ca/Sr ratio of 1:8.0 were able to incorporate and release much more ions, these particles reduced the cell viability of MC3T3-E1 cells because of the over dose released ion concentrations. In addition, the released ions from this ratio did not activate cell activity in all condition studied. In contrast, the particles with Si:Ca/Sr ratio of 1:1.3 had no toxic effect on the cell activity. Interestingly, the released ions from 75SrBGNPs and 100SrBGNPs significantly increased MC3T3-E1 cell activity. The results indicate that the partial and fully substitution of Sr for Ca in SrBGNPs are likely to be beneficial for MC3T3-E1 cells. 
Conclusion
The present study shows the effect of Si: Ca ratio on the properties of monodispersed BGNPs. Dual network modifiers enabled increased cation incorporation process into the NPs, while maintaining monodispersity and particle size. These particles maintained their dispersity in the neutral and basic condition compared to acidic condition and showed degradation in the acidic environment of simulated lysosomal fluid. Although the particles with Si:Ca/Sr ratio of 1:1.3 have less network modifier incorporation and released less ions, this ratio promoted MC3T3-E1 cell activity more than particles with the higher Si:Ca/Sr ratio.
